CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Exercise or conversion Chief Scientific Officer acquired 76,250 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 42,347 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 132,679 shares (option exercise)
- 4 Open-market sale Chief Scientific Officer sold 383 shares at $12.68 ($4,857)
- 4 Open-market sale Chief Financial Officer sold 1,388 shares at $12.66 ($17,568)
- 4 Open-market sale President and CEO sold 3,595 shares at $12.66 ($45,513)
- 4 Exercise or conversion Chief Scientific Officer acquired 1,050 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 3,875 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 10,800 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Chief Legal Officer acquired 45,518 shares (option exercise)
- 4 Gift Director gave 5,500 shares (gift)
- 4 Gift Chief Legal Officer gave 7,500 shares (gift)
- 4 Other disposition 10% owner disposed of 1,954,904 shares (other)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,041 shares (to pay taxes)
- 4 Open-market sale Chief Medical Officer sold 2,631 shares at $16.98 ($44,675)
- 4 Exercise or conversion Chief Medical Officer acquired 6,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 21 · 414 filings